Literature DB >> 23986598

Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells.

Jaturong Sewatanon1, Hao Liu, Paul D Ling.   

Abstract

Promyelocytic leukemia protein (PML) is an essential organizer of PML nuclear bodies (NBs), which carry out a variety of activities, including antiviral functions. Herpesviruses from all subfamilies encode proteins that counteract PML NB-mediated antiviral defenses by multiple mechanisms. However, because of the species specificity of herpesviruses, only a limited number of in vivo studies have been undertaken to investigate the effect of PML or PML NBs on herpesvirus infection. To address this central issue in herpesvirus biology, we studied the course of infection in wild-type and PML⁻/⁻ mice using murine gammaherpesvirus 68 (MHV68), which encodes a tegument protein that induces PML degradation. While acute infection in PML⁻/⁻ mice progressed similarly to that in wild-type mice, the lytic reactivation frequency was higher in peritoneal exudate cells, due to both an increase of MHV68 genome-positive cells and greater reactivation efficiency. We also detected a higher frequency of persistent infection in PML⁻/⁻ peritoneal cells. These findings suggest that the PML protein can repress the establishment or maintenance of gammaherpesvirus latency in vivo. Further use of the PML⁻/⁻ mouse model should aid in dissecting the molecular mechanisms that underlie the role of PML in gammaherpesvirus latency and may yield clues for how PML modulates herpesvirus latency in general.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986598      PMCID: PMC3807894          DOI: 10.1128/JVI.01696-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot.

Authors:  D Negorev; G G Maul
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

2.  Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit Poisson model to limiting dilution assays.

Authors:  T Bonnefoix; P Bonnefoix; M Callanan; P Verdiel; J J Sotto
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 3.  Natural history of murine gamma-herpesvirus infection.

Authors:  A A Nash; B M Dutia; J P Stewart; A J Davison
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

4.  ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.

Authors:  E Flaño; S M Husain; J T Sample; D L Woodland; M A Blackman
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

6.  Insights into chronic gamma-herpesvirus infections.

Authors:  Jae U Jung; Samuel H Speck
Journal:  Curr Opin Virol       Date:  2013-06-03       Impact factor: 7.090

7.  Effects of promyelocytic leukemia protein on virus-host balance.

Authors:  Weldy V Bonilla; Daniel D Pinschewer; Paul Klenerman; Valentin Rousson; Mirella Gaboli; Pier P Pandolfi; Rolf M Zinkernagel; Maria S Salvato; Hans Hengartner
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.

Authors:  Scott A Tibbetts; Linda F van Dyk; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects.

Authors:  Ana V Chee; Pascal Lopez; Pier Paolo Pandolfi; Bernard Roizman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells.

Authors:  Emilio Flaño; In-Jeong Kim; David L Woodland; Marcia A Blackman
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

View more
  6 in total

Review 1.  Animal models of tumorigenic herpesviruses--an update.

Authors:  Dirk P Dittmer; Blossom Damania; Sang-Hoon Sin
Journal:  Curr Opin Virol       Date:  2015-10       Impact factor: 7.090

Review 2.  TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity.

Authors:  Ricardo Rajsbaum; Adolfo García-Sastre; Gijs A Versteeg
Journal:  J Mol Biol       Date:  2013-12-12       Impact factor: 5.469

3.  Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.

Authors:  Nana Minkah; Kevin Chavez; Parth Shah; Thomas Maccarthy; Hui Chen; Nathaniel Landau; Laurie T Krug
Journal:  Virology       Date:  2014-03-13       Impact factor: 3.616

4.  Murine gammaherpesvirus 68 encodes a second PML-modifying protein.

Authors:  Jaturong Sewatanon; Paul D Ling
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

Review 5.  SUMO and KSHV Replication.

Authors:  Pei-Ching Chang; Hsing-Jien Kung
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

6.  Viral FGARAT ORF75A promotes early events in lytic infection and gammaherpesvirus pathogenesis in mice.

Authors:  Nick D Van Skike; Nana K Minkah; Chad H Hogan; Gary Wu; Peter T Benziger; Darby G Oldenburg; Mehmet Kara; Deborah M Kim-Holzapfel; Douglas W White; Scott A Tibbetts; Jarrod B French; Laurie T Krug
Journal:  PLoS Pathog       Date:  2018-02-01       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.